Compensation: -
Medical Affairs Associate
| Ad # | 1691574 |
| Contact | Aman |
| City | hackensack |
| Zip | NJ 07601 |
| Web site | Click to visit |
| Created | May 28, 2009 |
| Expires | November 27, 2009 |
| Viewed | 197 times |
Duties: Reviews and processes Serious Adverse Event (SAE) reports for clinical trials, received from clinical investigative sites. Is first line reviewer for SAEs. Must enter data into safety database (ARGUS)to include creating narrative summaries for MedWatch and CIOMS 1 Reports. Is responsible for processing SAE cases appropriately to regulatory agencies and other distributions as needed. Must have strong medical/clinical background to be able to interpret source documents, such as hospital discharge summaries, lab results, and other diagnostic tests to determine critical safety data. Will work within the assigned PV Team. After training and orientation, will work as an independent case owner, responsible for equitable case load. Skills: Skills: critical thinking; effective oral and written communication; professional ethics; effective teamwork; ability to work independently and within the team environment; technically proficient with basic MS Office programs; Education: Bachelor.s degree in nursing or medically equivalent degree and 1-2 years industry experience preferred. Two year RN is acceptable.
San Antonio, TX 78229
*****W2 CANDIDATES ONLY***
****NO THIRD PARTY PLEASE***
***PLEASE PROVIDE YOUR FULL CONTACT DETAILS IN THE BODY OF YOUR RESUME*****
Please email your resume at ronak@tech-observer.com
Contact Details:
Ronak Ajmera
Marketing specialist
W:201 489 7705 ext106
F: 201 215 9587
Email: ronak@tech-observer.com
www.tech-observer.com
Avoid scams and fraud
Signs of fraud: wire transfer, money orders, cashier checks, shipping, escrow, "transaction protection", "guarantee". Be safe by dealing locally.
Read more
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _